After participating in this educational activity, attendees should be able to:
1. Discuss epidemiology and mortality of IBD
2. Discuss disrupted immune responses in the gastrointestinal mucosa and putative disruptions in the gut microbiome as causative agents
3. Describe paradigms and strategies of management of IBD
4. Discuss postoperative medical management of IBD


Rohit Singhania, MBBS, SM
Assistant Professor of Medicine, UMMS-Baystate
Gastroenterologist, BMC 

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

Dr. Singhania receives Grant/Research Support from Janssen, Roche, Pfizer, and Bristol Myers Squibb.

None of the other members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.

Session date: 
02/25/2021 - 8:00am to 9:00am EST
Baystate Medical Center
759 Chestnut St.
Springfield, MA 01199
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours
  • 1.00 American Board of Surgery MOC

Please login or register to take this course.